OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trialPMID: 37385278 DOI: 10.1016/
34798068doi: 10.1016/S2213-8587(21)00210-2Review Lancet Diabetes Endocrinol. IF: 44.5Q12021 Dec
OL]. Lancet (London, England), 2018, 391(10125): 1023-1075.[3] Zeng H, Chen W, Zheng R, et al.-15
IF168.9|罕见肾病对肾衰竭的影响|《柳叶刀》https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00198
IF168.9|直肠青蒿素栓剂在哪些方面可以挽救生命?|《柳叶刀》https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23
IF168.9|蒽环类药物治疗早期乳腺癌的益处和风险|《柳叶刀》https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23
IF168.9|大剂量阿普利能满足糖尿病性黄斑水肿未满足的治疗需求吗?|《柳叶刀》https://www.thelancet.com/journals/lancet/article/PIIS0140
IF168.9|青少年癫痫患者的综合心理护理|《柳叶刀》https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24
2024年5月22日《Lancet》发表一项研究:背景:经导管主动脉瓣植入术是指南认可的治疗重度主动脉瓣狭窄的成熟方法。球囊扩张型 Myval 经导管心脏瓣膜(THV)系列与主动脉瓣环的精确尺寸